Key facts
- This page summarizes Angela Rossetti's Form 4 filing for AETHLON MEDICAL INC (AEMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Apr 2026, 17:00.
Angela Rossetti - 17 Apr 2026 Form 4 Insider Report for AETHLON MEDICAL INC (AEMD)
- Reporting relationship
- Director
- Issuer ticker
- AEMD
- Reported as of
- 17 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Apr 2026, 17:00:10 UTC
- Prior SEC filing
- 25 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Angela Rossetti filed Form 4 for AETHLON MEDICAL INC (AEMD) on 21 Apr 2026.
Change
- Previous filing in this sequence was filed on 25 Apr 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001580657
Primary reporting owner
Rossetti Angela
- Relationship
- Director
- Address
- 11555 SORRENTO VALLEY ROAD, STE 203, SAN DIEGO
- Signature
- /s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact
- Signature date
- 21 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AEMD
transaction
Common Stock
Award
- Transaction value
- Shares
- +21,815
- Change %
- +497%
- Price
- $2.29*
- Shares after
- 26,207
- Date
- 17 Apr 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.